Evidence map›Paper›PMID 33584711›Full record

ArticleFrontiers in immunology2020

Identification of Amino Acid Residues in Human IgM Fc Receptor (FcµR) Critical for IgM Binding.

Christopher M Skopnik, Khlowd Al-Qaisi, Rosaleen A Calvert, Philipp Enghard, Andreas Radbruch, Brian J Sutton, Hiromi Kubagawa

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Structural basis for Fc receptor recognition of immunoglobulin M.Nature structural & molecular biology · 2023
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Differences between Human and Mouse IgM Fc Receptor (FcµR).International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Christopher M SkopnikHumoral Immune Regulation, Deutsches Rheuma-Forschungszentrum, Berlin, Germany.
Khlowd Al-QaisiHumoral Immune Regulation, Deutsches Rheuma-Forschungszentrum, Berlin, Germany.
Rosaleen A CalvertRandall Centre for Cell and Molecular Biophysics, King's College London, London, United Kingdom.
Philipp EnghardDepartment of Nephrology and Medical Intensive Care, Charité-Universitätmedizin, Berlin, Germany.
Andreas RadbruchHumoral Immune Regulation, Deutsches Rheuma-Forschungszentrum, Berlin, Germany.
Brian J SuttonRandall Centre for Cell and Molecular Biophysics, King's College London, London, United Kingdom.
Hiromi KubagawaHumoral Immune Regulation, Deutsches Rheuma-Forschungszentrum, Berlin, Germany.
German Rheumatism Research Centre · DEKing's College London · GBCharité - Universitätsmedizin Berlin · DE

Funding

Biotechnology and Biological Sciences Research Council BB/K006142/1
6 · The paper itself

Abstract

Both non-immune "natural" and antigen-induced "immune" IgM are important for protection against infections and for regulation of immune responses to self-antigens. The roles of its Fc receptor (FcµR) in these IgM effector functions have begun to be explored. In the present study, by taking advantage of the difference in IgM-ligand binding of FcµRs of human (constitutive binding) and mouse (transient binding), we replaced non-conserved amino acid residues of human FcµR with mouse equivalents before establishment of cell lines stably expressing mutant or wild-type (WT) receptors. The resultant eight-different mutant FcµR-bearing cells were compared with WT receptor-bearing cells for cell-surface expression and IgM-binding by flow cytometric assessments using receptor-specific mAbs and IgM paraproteins as ligands. Three sites Asn66, Lys79-Arg83, and Asn109, which are likely in the CDR2, DE loop and CDR3 of the human FcµR Ig-like domain, respectively, were responsible for constitutive IgM binding. Intriguingly, substitution of Glu41 and Met42 in the presumed CDR1 with the corresponding mouse residues Gln and Leu, either single or more prominently in combination, enhanced both the receptor expression and IgM binding. A four-aa stretch of Lys24-Gly27 in the predicted A ß-strand of human FcµR appeared to be essential for maintenance of its proper receptor conformation on plasma membranes because of reduction of both receptor expression and IgM-binding potential when these were mutated. Results from a computational structural modeling analysis were consistent with these mutational data and identified a possible mode of binding of FcµR with IgM involving the loops including Asn66, Arg83 and Asn109 of FcµR interacting principally with the Cµ4 domain including Gln510 and to a lesser extent Cµ3 domain including Glu398, of human IgM. To our knowledge, this is the first experimental report describing the identification of amino acid residues of human FcµR critical for binding to IgM Fc.

Indexed as

Binding Sites, AntibodyModels, MolecularAmino AcidsAnimalsComplementarity Determining RegionsComputer SimulationHumansMiceReceptors, FcAmino AcidsComplementarity Determining Regionsimmunoglobulin M receptorReceptors, FcFc receptorFcμRFcμ receptorIgMpolymeric ig receptor

Identifiers

PMID33584711
PMCPMC7873564
OpenAlexW3122616415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.